Jonathan Schneck
Co-Chairman of Scientific Advisory BoardDr. Jonathan Schneck, MD, PhD is member of Scientific Advisory Board at NexImmune, Inc. since May 2021 and serves as its Co-Chairman of Scientific Advisory Board since May 2022. Dr. Schneck was Chairman of Clinical and Scientific Advisory Board at NexImmune, Inc. since January 04, 2012. He is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Dr. Schneck received his undergraduate degree from Yeshiva University. He earned his M.D.-Ph.D. in immunology from the Albert Einstein College of Medicine. After completing his degree, he trained in pediatrics at the Children's Hospital National Medical Center in Washington, D.C. From there he worked on the medical staff of the National Institute of Allergy and Immunology at the NIH in Bethesda and did his postdoctoral training at the Laboratory of Immunology. He joined the Johns Hopkins faculty in 1990 as a junior faculty member. His team pioneered the development of artificial white blood cells, called artificial antigen-presenting cells (aAPCs), which show promise in training animals' immune systems to fight diseases such as cancer.
Positions
- Company NameNexImmune, Inc.Stock CodeNEXIPositionCo-Chairman of Scientific Advisory BoardColleagues
- JTJohn TrainerConsultant
- KHKaren HaslbeckHead of Human Resources
- DPDaniel P. BednarikSenior Vice President of Molecular Engineering & Protein Design
- RDRobert Douglas KnightChief Medical Officer
- CRChad RubinSenior Vice President of Corporate Affairs
- JSJeffrey S. WeberChief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB
- GTGerald T. NepomChair of Autoimmune & Infectious Disease Scientific Advisory Board
- MPMiguel-Angel PeralesMember of Scientific Advisory Board
- JVJuan VarelaMember of Scientific Advisory Board
